Dietrich; Rango

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dietrich; Rango.The latest application filed is for "oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient".

Company Profile

0.33.34

Dietrich; Rango - Constance DE
Dietrich; Rango - Konstanz DE
Dietrich; Rango - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient Grant 9,468,598 - Dietrich , et al. October 18, 2	2016-10-18
Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient App 20150290178 - Dietrich; Rango ; et al.	2015-10-15
Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient App 20150290179 - Dietrich; Rango ; et al.	2015-10-15
Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient App 20150290180 - Dietrich; Rango ; et al.	2015-10-15
Dosage form containing (S)-pantoprazole as active ingredient Grant 8,758,817 - Dietrich , et al. June 24, 2	2014-06-24
Freeze-dried pantoprazole preparation and pantoprazole injection Grant 8,754,108 - Linder , et al. June 17, 2	2014-06-17
Dosage form containing pantoprazole as active ingredient Grant 8,703,192 - Anstett-Klein , et al. April 22, 2	2014-04-22
Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient App 20140031396 - Dietrich; Rango ; et al.	2014-01-30
Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient App 20140031397 - Dietrich; Rango ; et al.	2014-01-30
Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient App 20130345265 - Dietrich; Rango ; et al.	2013-12-26
Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles Grant 8,465,767 - Dietrich , et al. June 18, 2	2013-06-18
Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient App 20130131123 - DIETRICH; Rango ; et al.	2013-05-23
Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient Grant 8,431,154 - Dietrich , et al. April 30, 2	2013-04-30
Oral Dosage Form Containing A PDE 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidone As Excipient App 20110251244 - Dietrich; Rango ; et al.	2011-10-13
Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient Grant 7,988,999 - Dietrich , et al. August 2, 2	2011-08-02
Dosage Form Containing (s)-pantoprazole As Active Ingredient App 20110171303 - DIETRICH; Rango ; et al.	2011-07-14
Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient Grant 7,951,397 - Dietrich , et al. May 31, 2	2011-05-31
Pharmaceutical preparation comprising an active dispersed on a matrix Grant 7,951,398 - Dietrich , et al. May 31, 2	2011-05-31
Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient App 20110060016 - Dietrich; Rango ; et al.	2011-03-10
Preparation and administration form comprising an acid-labile active compound Grant 7,794,752 - Dietrich , et al. September 14, 2	2010-09-14
Preparation and administration form comprising an acid-labile active compound Grant 7,790,198 - Dietrich , et al. September 7, 2	2010-09-07
Preparation and administration form comprising an acid-labile active compound Grant 7,785,630 - Dietrich , et al. August 31, 2	2010-08-31
Binder Grant D620,976 - Dietrich August 3, 2	2010-08-03
Dosage form containing pantoprazole as active ingredient App 20090208571 - Dietrich; Rango ; et al.	2009-08-20
Method App 20090134211 - Dietrich; Rango	2009-05-28
Freeze-dried pantoprazole preparation and pantoprazole injection App 20090093522 - Linder; Rudolf ; et al.	2009-04-09
Method for the Provision of Clinical Trial Products App 20090020442 - Dietrich; Rango ; et al.	2009-01-22
Aerosol Container App 20080257339 - Dietrich; Rango ; et al.	2008-10-23
Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles App 20080226712 - Dietrich; Rango ; et al.	2008-09-18
Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles Grant 7,402,321 - Dietrich , et al. July 22, 2	2008-07-22
Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient Grant 7,357,943 - Linder , et al. April 15, 2	2008-04-15
Freeze-dried pantoprazole preparation and pantoprazole injection Grant 7,351,723 - Linder , et al. April 1, 2	2008-04-01
Novel preparation and administration form comprising an acid-labile active compound App 20080069882 - Dietrich; Rango ; et al.	2008-03-20
Pharmaceutical preparation comprising an active dispersed on a matrix App 20070122474 - Dietrich; Rango ; et al.	2007-05-31
Pharmaceutical preparation comprising an active dispersed on a matrix Grant 7,175,854 - Dietrich , et al. February 13, 2	2007-02-13
Rapidly disintegrating tablet comprising an acid-labile active ingredient Grant 7,147,869 - Dietrich , et al. December 12, 2	2006-12-12
Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient App 20060269600 - Dietrich; Rango ; et al.	2006-11-30
Oral administration form for pyridin-2-ylmethysulfinyl-1h-bezimidazoles App 20060263426 - Dietrich; Rango ; et al.	2006-11-23
Dosage form containing (s)-pantoprazole as active ingredient App 20060216346 - Dietrich; Rango ; et al.	2006-09-28
Oral pharmaceutical preparation for proton pump antagonists App 20060204568 - Dietrich; Rango ; et al.	2006-09-14
Novel preparation and administration form comprising an acid-labile active compound App 20060127477 - Dietrich; Rango ; et al.	2006-06-15
Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles Grant 7,041,313 - Dietrich , et al. May 9, 2	2006-05-09
Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient App 20050159492 - Dietrich, Rango ; et al.	2005-07-21
Administration form comprising an acid-labile active compound Grant 6,884,437 - Linder , et al. April 26, 2	2005-04-26
Freeze-dried pantoprazole preparation and pantoprazole injection App 20040220228 - Linder, Rudolf ; et al.	2004-11-04
Freeze-dried pantoprazole preparation and pantoprazole injection Grant 6,780,881 - Linder , et al. August 24, 2	2004-08-24
Rapidly disintegrating tablet comprising an acid-labile active ingredient App 20040110661 - Dietrich, Rango ; et al.	2004-06-10
Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient App 20040101558 - Dietrich, Rango ; et al.	2004-05-27
Pharmaceutical preparation comprising an active dispersed on a matrix App 20040058896 - Dietrich, Rango ; et al.	2004-03-25
Pharmaceutical preparation in the form of a supension comprising an acid-labile active ingredient App 20040052832 - Linder, Rudolf ; et al.	2004-03-18
Novel administration form comprising an acid-labile active compound App 20040022854 - Linder, Rudolf ; et al.	2004-02-05
Suppository composition which is a spray-dried suspension of an acid-labile proton pump inhibitor in a solvent solution of a sterol and polymer Grant 6,607,742 - Linder , et al. August 19, 2	2003-08-19
Administration form comprising an acid-labile active compound Grant 6,569,453 - Linder , et al. May 27, 2	2003-05-27
Freeze-dried pantoprazole preparation and pantoprazole injection App 20030003058 - Linder, Rudolf ; et al.	2003-01-02
Novel suppository form comprising an acid-labile active compound App 20020090397 - Linder, Rudolf ; et al.	2002-07-11
Suppository form comprising an acid-labile active compound Grant 6,383,510 - Linder , et al. May 7, 2	2002-05-07
Novel administration form comprising an acid-labile active compound App 20020025342 - Linder, Rudolf ; et al.	2002-02-28
Oral administration form for an acid liable active proton pump inhibitor Grant 6,328,993 - Linder , et al. December 11, 2	2001-12-11
Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole Grant 6,274,173 - Sachs , et al. August 14, 2	2001-08-14
Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors Grant 6,132,768 - Sachs , et al. October 17, 2	2000-10-17
Oral-administration forms of a medicament containing pantoprazol Grant 5,997,903 - Dietrich , et al. December 7, 1	1999-12-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.